1. Bandoh, K; Aoki, J; Taira, A; Tsujimoto, M; Arai, H; Inoue, K. (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
FEBS Lett., 478 (1-2): 159-65.
[PMID:10922489]
2. Choi, JW; Herr, DR; Noguchi, K; Yung, YC; Lee, CW; Mutoh, T; Lin, ME; Teo, ST; Park, KE; Mosley, AN; Chun, J. (2010) LPA receptors: subtypes and biological actions.
Annu. Rev. Pharmacol. Toxicol., 50: 157-86.
[PMID:20055701]
3. Contos, JJ; Fukushima, N; Weiner, JA; Kaushal, D; Chun, J. (2000) Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.
Proc. Natl. Acad. Sci. U.S.A., 97 (24): 13384-9.
[PMID:11087877]
4. Im, DS; Heise, CE; Harding, MA; George, SR; O'Dowd, BF; Theodorescu, D; Lynch, KR. (2000) Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
Mol. Pharmacol., 57 (4): 753-9.
[PMID:10727522]
5. Ohta, H; Sato, K; Murata, N; Damirin, A; Malchinkhuu, E; Kon, J; Kimura, T; Tobo, M; Yamazaki, Y; Watanabe, T; Yagi, M; Sato, M; Suzuki, R; Murooka, H; Sakai, T; Nishitoba, T; Im, DS; Nochi, H; Tamoto, K; Tomura, H; Okajima, F. (2003) Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Mol. Pharmacol., 64 (4): 994-1005.
[PMID:14500756]
6. Santos, WL; Heasley, BH; Jarosz, R; Carter, KM; Lynch, KR; Macdonald, TL. (2004) Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.
Bioorg. Med. Chem. Lett., 14 (13): 3473-6.
[PMID:15177455]
7. Swaney, JS; Chapman, C; Correa, LD; Stebbins, KJ; Bundey, RA; Prodanovich, PC; Fagan, P; Baccei, CS; Santini, AM; Hutchinson, JH; et al.. (2010) A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
Br. J. Pharmacol., 160 (7): 1699-713.
[PMID:20649573]
8. Virag, T; Elrod, DB; Liliom, K; Sardar, VM; Parrill, AL; Yokoyama, K; Durgam, G; Deng, W; Miller, DD; Tigyi, G. (2003) Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.
Mol. Pharmacol., 63 (5): 1032-42.
[PMID:12695531]
9. Williams, JR; Khandoga, AL; Goyal, P; Fells, JI; Perygin, DH; Siess, W; Parrill, AL; Tigyi, G; Fujiwara, Y. (2009) Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
J. Biol. Chem., 284 (25): 17304-19.
[PMID:19366702]